See what questions
a doctor would ask.
The manufacturer of Celebrex, Pfizer, refuses to withdraw it's product from the market despite the fact that research has shown that it can increase the risk of heart attack if taken in low doses. This side effect was recently noticed during a cancer prevention trial which was stopped suddenly when it was found that Celebrex was associated with a tripled risk of cardiovascular events when taken in large doses. Celebrex belongs to the same class of drugs as the recently banned Vioxx - Cox-2 inhibitors. In fact, the whole class of Cox-2 inhibitors is being scrutinized for their association with increased risk of cardiovascular events. Even the FDA supports the decision to leave Celebrex on the market but warns consumers to discuss alternative medications with their doctor.
Source: summary of medical news story as reported by Health Talk
About: Concerns over Celebrex use mounting
Date: 18 December 2004
Source: Health Talk
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City